top headlines
OSF HealthCare is expanding its use of RapidAI’s clinical AI [...]
Zilucoplan has been accepted for restricted use in NHS Scotland [...]
Movers & Shakers
sponsored content
In this exclusive interview with Liza Laws for Discover Pharma, [...]
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
Other news
Grifols has completed patient follow-up in its Phase 3 SPARTA [...]
Acarizax has been accepted for use in NHS Scotland for [...]
AstronauTx has exercised its option to acquire worldwide rights to [...]
Kupando has dosed the first patient in a Phase 1 [...]
Adneuris Therapeutics has granted Maruishi Pharmaceutical exclusive rights to develop [...]
BlueWind Medical has received FDA 510(k) clearance for Revi Extend, [...]
